EMD-39372

Single-particle
3.27 Å
EMD-39372
3D View Gallery
Deposition: 05/03/2024
Map released: 12/03/2025
Last modified: 12/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-39372

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8ykh summary report (pdf.gz) Map-8ykh FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 spike glycoprotein in complex with NT-108 scFv focused on RBD and NT-108 scFv interface

EMD-39372

Single-particle
3.27 Å
EMD-39372
3D View Gallery
Deposition: 05/03/2024
Map released: 12/03/2025
Last modified: 12/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein in complex with NT-108 scFv
Fitted models: 8ykh

Deposition Authors: Anraku Y, Kita S, Onodera T, Tadokoro T, Ito S, Adachi Y, Kotaki R, Suzuki T, Hashiguchi T, Takahashi Y, Maenaka K

Structural basis for potent neutralization activity of SARS-CoV-2 antibody, NT-108
Anraku Y, Maenaka K
To Be Published